{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:46:57Z","timestamp":1794556017891,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7769","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41586-019-1437-3","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T14:03:40Z","timestamp":1564581820000},"page":"397-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":629,"title":["Dietary methionine influences therapy in mouse cancer models and alters human metabolism"],"prefix":"10.1038","volume":"572","author":[{"given":"Xia","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney M.","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John P.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ciccarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Calcagnotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Mentch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Ables","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailendra N.","family":"Nichenametla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Locasale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cancerbio-030518-055855","volume":"3","author":"MD Goncalves","year":"2019","unstructured":"Goncalves, M. D., Hopkins, B. D. & Cantley, L. C. Dietary fat and sugar in promoting cancer development and progression. Annual Rev. Cancer Biol. 3, 255\u2013273 (2019).","journal-title":"Annual Rev. Cancer Biol."},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","volume":"169","author":"JR Cantor","year":"2017","unstructured":"Cantor, J. R. et al. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 169, 258\u2013272 (2017).","journal-title":"Cell"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ncb3272","volume":"17","author":"S Tardito","year":"2015","unstructured":"Tardito, S. et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol. 17, 1556\u20131568 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","volume":"24","author":"X Liu","year":"2016","unstructured":"Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E. & Locasale, J. W. Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers. Cell Metab. 24, 728\u2013739 (2016).","journal-title":"Cell Metab."},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"OD Maddocks","year":"2013","unstructured":"Maddocks, O. D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542\u2013546 (2013).","journal-title":"Nature"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372\u2013376 (2017).","journal-title":"Nature"},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1158\/0008-5472.CAN-14-2643-T","volume":"74","author":"SP Gravel","year":"2014","unstructured":"Gravel, S. P. et al. Serine deprivation enhances antineoplastic activity of biguanides. Cancer Res. 74, 7521\u20137533 (2014).","journal-title":"Cancer Res."},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41586-018-0316-7","volume":"559","author":"N Kanarek","year":"2018","unstructured":"Kanarek, N. et al. Histidine catabolism is a major determinant of methotrexate sensitivity. Nature 559, 632\u2013636 (2018).","journal-title":"Nature"},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature25465","volume":"554","author":"SRV Knott","year":"2018","unstructured":"Knott, S. R. V. et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554, 378\u2013381 (2018).","journal-title":"Nature"},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","volume":"22","author":"SJ Mentch","year":"2015","unstructured":"Mentch, S. J. et al. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab. 22, 861\u2013873 (2015).","journal-title":"Cell Metab."},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mam.2016.09.001","volume":"54","author":"X Gao","year":"2017","unstructured":"Gao, X., Reid, M. A., Kong, M. & Locasale, J. W. Metabolic interactions with cancer epigenetics. Mol. Aspects Med. 54, 50\u201357 (2017).","journal-title":"Mol. Aspects Med."},{"key":"1437_CR13","first-page":"269","volume":"123","author":"N Orentreich","year":"1993","unstructured":"Orentreich, N., Matias, J. R., DeFelice, A. & Zimmerman, J. A. Low methionine ingestion by rats extends life span. J. Nutr. 123, 269\u2013274 (1993).","journal-title":"J. Nutr."},{"key":"1437_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4592","volume":"5","author":"BC Lee","year":"2014","unstructured":"Lee, B. C. et al. Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status. Nat. Commun. 5, 3592 (2014).","journal-title":"Nat. Commun."},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.metabol.2013.06.012","volume":"62","author":"VL Malloy","year":"2013","unstructured":"Malloy, V. L. et al. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Metabolism 62, 1651\u20131661 (2013).","journal-title":"Metabolism"},{"key":"1437_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051357","volume":"7","author":"GP Ables","year":"2012","unstructured":"Ables, G. P., Perrone, C. E., Orentreich, D. & Orentreich, N. Methionine-restricted C57BL\/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS ONE 7, e51357 (2012).","journal-title":"PLoS ONE"},{"key":"1437_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1474-9726.2006.00220.x","volume":"5","author":"VL Malloy","year":"2006","unstructured":"Malloy, V. L. et al. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 5, 305\u2013314 (2006).","journal-title":"Aging Cell"},{"key":"1437_CR18","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.celrep.2016.05.035","volume":"15","author":"Z Ser","year":"2016","unstructured":"Ser, Z. et al. Targeting one carbon metabolism with an antimetabolite disrupts pyrimidine homeostasis and induces nucleotide overflow. Cell Reports 15, 2367\u20132376 (2016).","journal-title":"Cell Reports"},{"key":"1437_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1515\/bmc-2017-0003","volume":"8","author":"IR Miousse","year":"2017","unstructured":"Miousse, I. R. et al. One-carbon metabolism and ionizing radiation: a multifaceted interaction. Biomol. Concepts 8, 83\u201392 (2017).","journal-title":"Biomol. Concepts"},{"key":"1437_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale, J. W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572\u2013583 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1073\/pnas.73.5.1523","volume":"73","author":"RM Hoffman","year":"1976","unstructured":"Hoffman, R. M. & Erbe, R. W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc. Natl Acad. Sci. USA 73, 1523\u20131527 (1976).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1437_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1207\/s15327914nc5402_6","volume":"54","author":"D Komninou","year":"2006","unstructured":"Komninou, D., Leutzinger, Y., Reddy, B. S. & Richie, J. P. Jr. Methionine restriction inhibits colon carcinogenesis. Nutr. Cancer 54, 202\u2013208 (2006).","journal-title":"Nutr. Cancer"},{"key":"1437_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2367-1","volume":"16","author":"JR Hens","year":"2016","unstructured":"Hens, J. R. et al. Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC Cancer 16, 349 (2016).","journal-title":"BMC Cancer"},{"key":"1437_CR24","first-page":"5676","volume":"53","author":"H Guo","year":"1993","unstructured":"Guo, H. et al. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res. 53, 5676\u20135679 (1993).","journal-title":"Cancer Res."},{"key":"1437_CR25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","volume":"26","author":"LB Saltz","year":"2008","unstructured":"Saltz, L. B. et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J. Clin. Oncol. 26, 2013\u20132019 (2008).","journal-title":"J. Clin. Oncol."},{"key":"1437_CR26","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","volume":"28","author":"JY Douillard","year":"2010","unstructured":"Douillard, J. Y. et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J. Clin. Oncol. 28, 4697\u20134705 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1437_CR27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nm1602","volume":"13","author":"DG Kirsch","year":"2007","unstructured":"Kirsch, D. G. et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat. Med. 13, 992\u2013997 (2007).","journal-title":"Nat. Med."},{"key":"1437_CR28","doi-asserted-by":"publisher","first-page":"278ra34","DOI":"10.1126\/scitranslmed.aaa4214","volume":"7","author":"EJ Moding","year":"2015","unstructured":"Moding, E. J. et al. Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy. Sci. Transl. Med. 7, 278ra34 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01635580701525877","volume":"60","author":"X Durando","year":"2008","unstructured":"Durando, X. et al. Optimal methionine-free diet duration for nitrourea treatment: a phase I clinical trial. Nutr. Cancer 60, 23\u201330 (2008).","journal-title":"Nutr. Cancer"},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000313700","volume":"78","author":"X Durando","year":"2010","unstructured":"Durando, X. et al. Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study. Oncology 78, 205\u2013209 (2010).","journal-title":"Oncology"},{"key":"1437_CR31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/1535-7163.MCT-11-0937","volume":"11","author":"MK Kim","year":"2012","unstructured":"Kim, M. K. et al. Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer. Mol. Cancer Ther. 11, 1500\u20131509 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"1437_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038422","volume":"7","author":"JM Uronis","year":"2012","unstructured":"Uronis, J. M. et al. Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS ONE 7, e38422 (2012).","journal-title":"PLoS ONE"},{"key":"1437_CR33","volume":"2","author":"O Udofot","year":"2016","unstructured":"Udofot, O. et al. Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse. J. Nat. Sci. 2, e171 (2016).","journal-title":"J. Nat. Sci."},{"key":"1437_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1242\/dmm.009084","volume":"5","author":"CL Lee","year":"2012","unstructured":"Lee, C. L. et al. Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice. Dis. Model. Mech. 5, 397\u2013402 (2012).","journal-title":"Dis. Model. Mech."},{"key":"1437_CR35","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1172\/JCI73932","volume":"124","author":"EJ Moding","year":"2014","unstructured":"Moding, E. J. et al. Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. J. Clin. Invest. 124, 3325\u20133338 (2014).","journal-title":"J. Clin. Invest."},{"key":"1437_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1074\/mcp.M114.044859","volume":"14","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. High-resolution metabolomics with acyl-CoA profiling reveals widespread remodeling in response to diet. Mol. Cell. Proteomics 14, 1489\u20131500 (2015).","journal-title":"Mol. Cell. Proteomics"},{"key":"1437_CR37","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1021\/ac403845u","volume":"86","author":"X Liu","year":"2014","unstructured":"Liu, X., Ser, Z. & Locasale, J. W. Development and quantitative evaluation of a high-resolution metabolomics technology. Anal. Chem. 86, 2175\u20132184 (2014).","journal-title":"Anal. Chem."},{"key":"1437_CR38","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/nprot.2008.131","volume":"3","author":"J Yuan","year":"2008","unstructured":"Yuan, J., Bennett, B. D. & Rabinowitz, J. D. Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nat. Protocols 3, 1328\u20131340 (2008).","journal-title":"Nat. Protocols"},{"key":"1437_CR39","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.1073\/pnas.150242097","volume":"97","author":"NS Holter","year":"2000","unstructured":"Holter, N. S. et al. Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proc. Natl Acad. Sci. USA 97, 8409\u20138414 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1437_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nbt.2488","volume":"31","author":"I Thiele","year":"2013","unstructured":"Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419\u2013425 (2013).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1437-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:58:06Z","timestamp":1684605486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1437-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":40,"journal-issue":{"issue":"7769","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1437-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736297590.793564135","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was amended to correct the Peer review information, which was originally incorrect.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W.L. and X.G. have patents related to targeting amino acid metabolism in cancer therapy. D.G.K. is a co-founder and has equity in XRAD Therapeutics, a company developing radiosensitizing agents. He also has patents related to radiosensitizing agents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}